Skip to main content

Table 1 Baseline characteristics of patients receiving thrombolytic treatment in mothership, drip-and-ship, and ship-and-drip paradigms

From: Outcomes of thrombolytic therapy in acute ischemic stroke: mothership, drip-and-ship, and ship-and-drip paradigms

 Overall (n = 273)Mothership (n = 147)Drip-and-Ship (n = 87)Ship-and-Drip (n = 39)P value
Age, med (IQR)66 (22)68 (22)64 (22)60 (29)0.22
Female, n (%)123 (45.1%)71 (48.3%)34 (39.1%)18 (46.2%)0.39
Initial NIHSS, med (IQR)10 (11)8 (10)11 (13)12 (12)0.18
Risk factors, n (%)
 - Hypertension160 (58.6%)84 (57.1%)50 (57.5%)26 (66.7%)0.54
 - Diabetes mellitus71 (26.0%)36 (24.5%)23 (26.4%)12 (30.8%)0.73
 - Dyslipidemia99 (36.3%)58 (39.5%)24 (27.6%)17 (43.6%)0.11
 - History of stroke42 (15.4%)28 (19.0%)11 (12.6%)3 (7.7%)0.15
 - History of myocardial infarction25 (9.2%)17 (11.6%)6 (6.9%)2 (5.1%)0.31
Underlying malignancy19 (7.0%)15 (10.2%)2 (2.3%)2 (5.1%)0.06
Stroke subtypes, n (%)    0.07
 - Large vessel38 (13.9%)17 (11.6%)20 (23.0%)1 (2.6%) 
 - Small vessel55 (20.1%)34 (23.1%)15 (17.2%)6 (15.4%) 
 - Cardioembolic99 (36.3%)52 (35.4%)29 (33.3%)18 (46.2%) 
 - Other determined2 (0.7%)2 (1.4%)0 (0%)0 (0%) 
 - Undetermined79 (28.9%)42 (28.6%)23 (26.4%)14 (35.9%) 
Thrombectomy24 (8.8%)13 (8.8%)10 (11.5%)1 (2.6%)0.26